While a number of stem cell-specific markers have been identified in lung cancer stem cells, such as CD166 and aldehyde dehydrogenase (ALDH), as well as ATP binding cassette subfamily G member 2 (ABCG2),8,9 to date, valid therapy targeting the eradication of lung cancer stem cells remains a tough challenge. The gene discussed is LDHA; the disease is lung carcinoma.